Chiodo Keri A, Läck Christopher M, Roberts David C S
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Psychopharmacology (Berl). 2008 Nov;200(4):465-73. doi: 10.1007/s00213-008-1222-8. Epub 2008 Jul 6.
To date, there is no medication specifically approved for cocaine addiction. Agonist medications are used clinically in the treatment of other addictions, which suggests that this method of drug therapy could potentially be successful in treating cocaine addiction as well.
The objective of this study was to determine the effect of extended D-amphetamine treatment on responding on a progressive ratio (PR) schedule reinforced by cocaine.
Rats were trained to self-administer cocaine (0.19, 0.38, 0.75, or 1.5 mg/kg/injection) or food on a PR schedule. After stable baseline breakpoints (the number of reinforcers earned in one session) were established over 3 days, animals were implanted with osmotic mini-pumps that continuously delivered D-amphetamine (5 mg/kg/day) for a duration of either 7 or 14 days. Breakpoints were then determined during and/or after this treatment period.
Rats demonstrated dose-dependent decreases in cocaine-reinforced responding over the D-amphetamine treatment period. Breakpoints for doses of 0.75 mg/kg/injection and below decreased significantly when compared to baseline and remained decreased for up to 14 days after mini-pump removal, whereas those for the highest dose of cocaine remained unchanged. Additionally, D-amphetamine treatment during a 14-day abstinence period from cocaine self-administration had no effect on breakpoints when tested the day after mini-pump removal.
These data suggest that the reduction in cocaine-reinforced responding after continuous D-amphetamine treatment cannot be accounted for by tolerance alone. Instead, the roles of learning and the interaction between cocaine and D-amphetamine must be considered and examined in future studies.
迄今为止,尚无专门批准用于治疗可卡因成瘾的药物。激动剂药物在临床上用于治疗其他成瘾问题,这表明这种药物治疗方法可能同样有望成功治疗可卡因成瘾。
本研究的目的是确定延长使用D-苯丙胺治疗对可卡因强化的渐进比率(PR)程序反应的影响。
训练大鼠在PR程序上自我给药可卡因(0.19、0.38、0.75或1.5mg/kg/注射)或食物。在3天内建立稳定的基线断点(一次实验中获得的强化物数量)后,给动物植入渗透微型泵,持续输注D-苯丙胺(5mg/kg/天),持续7天或14天。然后在该治疗期间和/或之后确定断点。
在D-苯丙胺治疗期间,大鼠可卡因强化反应呈剂量依赖性下降。与基线相比,0.75mg/kg/注射及以下剂量的断点显著降低,并且在移除微型泵后长达14天仍保持下降,而最高剂量可卡因的断点保持不变。此外,在停止可卡因自我给药14天的禁欲期内进行D-苯丙胺治疗,在移除微型泵后的第二天进行测试时,对断点没有影响。
这些数据表明,连续D-苯丙胺治疗后可卡因强化反应的降低不能仅用耐受性来解释。相反,在未来的研究中必须考虑并研究学习以及可卡因与D-苯丙胺之间相互作用的作用。